A prospective observational survey on the long-term effect of ldl apheresis on drug-resistant nephrotic syndrome

Nephron Extra

Volumn 5, Issue 2, 2015, Pages 58-66

  Muso, Eri ^a   Mune, Masatoshi ^d   Hirano, Tsutomu ^e   Hattori, Motoshi ^g   Kimura, Kenjiro ^k   Watanabe, Tsuyoshi ^l   Yokoyama, Hitoshi ^m   Sato, Hiroshi ⁿ   Uchida, Shunya ^h   Wada, Takashi ^o   Shoji, Tetsuo ^b   Takemura, Tsukasa ^c   Yuzawa, Yukio ^p   Ogahara, Satoru ^q   Sugiyama, Satoshi ^s   Iino, Yasuhiko ⁱ   Sakai, Soichi ^j   Ogura, Yousuke ^f   Yukawa, Susumu ^u   Nishizawa, Yoshiki ^b   Yorioka, Noriaki ^v   Imai, Enyu ^w   Matsuo, Seiichi ^t   Saito, Takao ^r   more..

^a Kitano Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Takaishi Fujii Hospital   (Japan)

^e Metabolism and Endocrinology ^*  (Japan)

^f SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NIPPON MEDICAL SCHOOL   (Japan)

^j Siratori Clinic   (Japan)

^k ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^m KANAZAWA MEDICAL UNIVERSITY   (Japan)

ⁿ TOHOKU UNIVERSITY   (Japan)

^o KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^p FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q Departments of Internal Medicine   (Japan)

^r FUKUOKA UNIVERSITY   (Japan)

^s Division of Nephrology   (Japan)

^t NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^u Department of Internal Medicine   (Japan)

^v General Incorporated Association Hiroshima Kidney Organization   (Japan)

^w Nakayamadera Imai Clinic   (Japan)

more..

Author keywords

Drug resistant nephrotic syndrome; LDL apheresis; Long term outcome; Nephrotic syndrome; POLARIS study; Prospective study; Urinary protein

Indexed keywords

ALBUMIN; CREATININE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANAPHYLACTOID PURPURA; APHERESIS; ARTICLE; BRAIN INFARCTION; CAUSE OF DEATH; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY DISEASE; LUNG CANCER; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY; NEPHRITIS; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; REMISSION; THERAPY EFFECT;

EID: 85020266651     PISSN: None     EISSN: 16645529     Source Type: Journal    
DOI: 10.1159/000437338     Document Type: Article

References (33)

1. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982;2:1309–1311.
2. Yokoyama S, Hayashi R, Satani M, Yamamoto A: Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613–622.
3. Tojo K, Sakai S, Miyahara T: Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). Nihon Jinzo Gakkai Shi 1988;30:1153–1160.
4. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S: Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 1994;9:257–264.
5. Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki S, Kuwahara T, Takamitsu Y, Tsubakihara Y; Kansai FGS LDL Apheresis Treatment (K-FLAT) Study Group: Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy. Nephron 2001; 89:408–415.
6. Yokoyama K, Sakai S, Sigematsu T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T: LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy. Clin Nephrol 1998;50:1–7.
7. Muso E, Mune M, Yorioka N, Nishizawa Y, Hirano T, Hattori M, Sugiyama S, Watanabe T, Kimura K, Yokoyama H, Sato H, Saito T: Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS). Clin Nephrol 2007;67:341–344.
8. Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K: A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis 2003;42:1121–1130.
9. Kawasaki Y, Suzuki S, Matsumoto A, Takano K, Suyama K, Hashimoto K, Suzuki J, Suzuki H, Hosoya M: Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis. Pediatr Nephrol 2007;22:889–892.
10. Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T: Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS study. Clin Exp Nephrol 2015; 19:379–386.
11. Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori: Long-term prognosis of membranous nephropathy. Clin Nephrol 1986;25:64–69.
12. Kobayashi T, Ando Y, Umino T, Miyata Y, Muto S, Hironaka M, Asano Y, Kusano E: Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy. Clin Nephrol 2006;65:423–426.
13. Ideura T, Hora K, Kaneko Y, Yamazaki T, Tokunaga S, Shigematsu H, Kiyosawa K: Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. Transplant Proc 2000;32:223–226.
14. Sato Y, Tsunoda S, Nozue T, Pan Q, Wakasugi H, Yoshimura A: Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Intern Med 2012;51:2597–2602.
15. Daimon S, Saga T, Nakayama M, Nomura Y, Chikaki H, Dan K, Koni I: Dextran sulphate cellulose columns for the treatment of nephrotic syndrome due to inactive lupus nephritis. Nephrol Dial Transplant 2000;15:235–238.
16. Kamijo Y, Kaneko Y, Ichikawa T, Kobayashi N, Koyama T, Kakegawa T, Kamijo H, Kono K, Minami S, Tanaka N, Arakura H, Hirata M, Higuchi M, Kiyosawa K, Hora K: A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis. Ther Apher 2002;6:459–462.
17. Shiraishi N, Kitamura K, Hayata M, Ogata T, Tajiri-Okamura K, Nakayama Y, Kohda Y, Tomita K, Mukoyama M: Low-density lipoprotein apheresis for proteinuria in lupus nephritis with intraglomerular foam cells containing cholesterol crystals. Am J Kidney Dis 2015;65:490–493.
18. Kobayashi S: LDL-apheresis for diabetic nephropathy: a possible new tool. Nephron 1998;79:505–506.
19. Nakao T, Yoshino M, Matsumoto H, Okada T, Han M, Hidaka H, Shino T, Yamada C, Nagaoka Y, Miyahara T: Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy. Kidney Int Suppl 1999;71:S206–S209.
20. Nakamura T, Kawagoe Y, Ogawa H, Ueda Y, Hara M, Shimada N, Ebihara I, Koide H: Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy. Am J Kidney Dis 2005;45:48–53.
21. Sato E, Amaha M, Nomura M, Matsumura D, Ueda Y, Nakamura T: LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: a retrospective analysis. Diabetes Res Clin Pract 2014;106:241–246.
22. Schlondorff D: Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 1993;22:72–82.
23. Diamond JR, Pesek I, McCarter MD, Karnovsky MJ: Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia. Am J Pathol 1989;135:711–718.
24. Knisel W, Di Nicuolo A, Pfohl M, Müller H, Risler T, Eggstein M, Seifried E: Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med 1993;234:479–487.
25. Tasaki H, Tsuda Y, Yamashita K, Toyokawa T, Yashiro A, Osajima A, Nakashima Y, Kuroiwa A: Removal of plasma fibrinogen by LDL apheresis. Jpn J Apheresis 1997;16:263.
26. Ingulli E, Tejani A: Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol 1992;3:254–259.
27. Leon C, Jia J, Qiu G, Hill JS, Wasan KM: Modification in low density lipoprotein receptor expression affects cyclosporin A cellular uptake and cytotoxicity. J Pharm Sci 2008;97:2350–2361.
28. Korbet SM: Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 1999;14:68–73.
29. Velosa JA, Holley KE, Torres VE, Offord KP: Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 1983;58:568–577.
30. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H; Research Group on Progressive Renal Diseases in Japan: Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 2004;65:1400–1407.
31. Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E: Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 1997;51:901–907.
32. Coppo R, D’Amico G: Factors predicting progression of IgA nephropathies. J Nephrol 2005;18:503–512.
33. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F: Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991;18:12–19.